SCHEMBL6273540

SCHEMBL6273540

COc1ccccc1NCc1cc(N)ccc1N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.49
ALDH1A1 P00352 4/20 0.49
MAPK1 P28482 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
KDM4E B2RXH2 4/20 0.48
HPGD P15428 2/20 0.48
GAA P10253 5/20 0.46
HDAC1 Q13547 1/20 0.46
RECQL P46063 2/20 0.45
APAF1 O14727 1/20 0.45
TSHR P16473 2/20 0.45
POLB P06746 1/20 0.45
CRHBP P24387 1/20 0.45
CRHR2 Q13324 1/20 0.45
ACHE P22303 1/20 0.44
CHRM2 P08172 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HTT P42858 2/20 0.42
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6742217 0.89 L3MBTL1 (0.43) MAPTALDH1A1MAPK1L3MBTL1KDM4E
SCHEMBL6273612 0.88 MAPT (0.49) MAPTALDH1A1MAPK1L3MBTL1KDM4E
SCHEMBL7157974 0.86 GAA (0.53) MAPTALDH1A1MAPK1L3MBTL1KDM4E
SCHEMBL6742538 0.81 GAA (0.41) MAPTALDH1A1MAPK1L3MBTL1KDM4E
SCHEMBL6269483 0.81 MAPT (0.43) MAPTALDH1A1KDM4EHPGDGAA
SCHEMBL6272725 0.81 GAA (0.39) MAPTALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL6272131 0.80 MAPT (0.51) MAPTALDH1A1MAPK1L3MBTL1KDM4E
SCHEMBL6740339 0.80 CA12 (0.40) MAPTALDH1A1MAPK1L3MBTL1KDM4E
SCHEMBL6272546 0.78 L3MBTL1 (0.45) MAPTALDH1A1MAPK1L3MBTL1KDM4E
SCHEMBL6272864 0.78 ALDH1A1 (0.48) MAPTALDH1A1MAPK1L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1116711-B1 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds WELLA AG (DE) 2005-12-14 EP disclosed
US-6800097-B2 FOR DYEING KERATIN FIBERS; HAIR DYES WELLA AKTIENGESELLSCHAFT (DE) 2004-10-05 US disclosed
US-6780998-B2 DEVELOPER-COUPLER SUBSTANCE COMBINATION HAIR DYES WELLA AKTIENGESELLSCHAFT (DE) 2004-08-24 US disclosed
US-20030070241-A1 Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) 2003-04-17 US disclosed
US-20020189033-A1 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) 2002-12-19 US disclosed
US-6436152-B1 Substituted 2-aminoalky-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same WELLA AKTIENGESELLSCHAFT (DE) 2002-08-20 US disclosed
EP-1116711-A2 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds Wella Aktiengesellschaft (DE) 2001-07-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020189033-A1 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same DDT, CYP1B1, ALDH7A1 MAPT 3205/4885ALDH1A1 8/4885MAPK1 1101/4885
US-20030070241-A1 Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same DDT, ALDH7A1, DDC MAPT 3672/4885ALDH1A1 7/4885MAPK1 1137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.